Supported by 12 clinical trials

Identified and isolated in 2004, Lab4 probiotics contains four proprietary bacteria strains – Lactobacillus acidophilus (CUL60), Lactobacillus acidophilus (CUL21), Bifidobacterium animalis subsp. lactis (CUL34) and Bifidobacterium bifidum (CUL20).

The Lab4 Probiotics blend is supported by 12 clinical trials across a wide range of conditions at doses ranging from 12.5 billion CFUs to 50 billion CFU’s per day.

2016

Lactobacillus plantarum CUL66 and Cholesterol Study

Lactobacillus plantarum CUL66 can impact cholesterol homeostasis in Caco-2 enterocytes

2017

Lab4 and Cholesterol Study

The anti-cholesterolaemic effect of a consortium of probiotics: An acute study in C57BL/6J mice (Part 1)

2017

Lab4P and Cholesterol Study

The anti-cholesterolaemic effect of a consortium of probiotics: An acute study in C57BL/6J mice (Part 2)

2017

Lab4 and Memory Improvement Study

Long-term multi-species Lactobacillus and Bifidobacterium dietary supplement enhances memory and changes regional brain metabolites in middle-aged rats

2019

Lab4 Consortia and Neuroprotection

In vitro neuroprotective activities of two distinct probiotic consortia

Scroll to Top